LTGO-33 is a selective, state-independent, and potent preclinical small molecule NaV1.8 inhibitor. LTGO-33 engages a novel interaction site and possesses a mechanism of action previously unreported for the treatment of pain disorders.
MedKoo Cat#: 126485
Name: LTGO-33
CAS#: 2834106-06-6
Chemical Formula: C21H17F4N3O3S
Exact Mass: 467.0927
Molecular Weight: 467.44
Elemental Analysis: C, 53.96; H, 3.67; F, 16.26; N, 8.99; O, 10.27; S, 6.86
The following data is based on the product molecular weight 467.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |